Summit Therapeutics Announces Clinical Trial Collaboration with GSK to Evaluate Ivonescimab in Combination with GSK's B7-H3 Antibody Drug Conjugate (ADC)Business Wire • 01/12/26
GSK's Chronic Hepatitis B Drug Meets Goals in Two Late-Stage StudiesZacks Investment Research • 01/08/26
GSK Licenses Noetik's AI Foundation Models in Anchor Partnership to Transform Cancer Therapeutic Research and DevelopmentBusiness Wire • 01/08/26
GSK/Ionis Partnered Investigational Drug Shows Strong Results In Large Hepatitis B StudiesBenzinga • 01/07/26
Samsung Biologics Expands U.S. Manufacturing Capabilities with Strategic Acquisition of Human Genome Sciences from GSKPRNewsWire • 12/21/25
Nine pharmaceutical companies including Bristol-Myers Squibb, GSK and Merck agreed to lower the prices that certain federal government programs and patients payWSJ • 12/19/25
GSK's Nucala for COPD and Depemokimab for Asthma Get CHMP Nod in EUZacks Investment Research • 12/15/25